Cyberonics (CYBX) Announces Epilepsy Technology Collaborations
More News related to CYBX
- Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference
- Piper Jaffray Upgrades Cyberonics, Inc. (CYBX) to Overweight
- After-Hours Movers 11/18: DCI, CYBX, LTD Higher; JACK, NMM, AFFY, HOTT, SMTC, MVIS Lower
- Cyberonics (CYBX) Posts Q2 adj.-EPS of $0.32, Tops Street; Boosts FY10 Revenue Guidance
- Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Second Quarter
Cyberonics, Inc. (Nasdaq: CYBX) announced two collaborations in the field of EEG-based seizure detection to build on its position as the leader in medical devices for epilepsy.
On October 1, 2009, Cyberonics entered into a License Agreement with NeuroVista Corporation, providing Cyberonics with access to a range of technology and patents in exchange for payments extending through April 2011. The NeuroVista technology will enable Cyberonics to accelerate its program for development of an implantable pulse generator for stimulating the vagus nerve in response to EEG-based detection of a seizure and includes technology related to an algorithm for seizure detection, a rechargeable battery system, wireless communication, and an implantable lead.
Related Categories
Corporate NewsFDA
Stocks Mentioned
+0.13Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
